Surmodics expects to close GTCR acquisition after FTC drops appeal Nov 17, 2025 06:02AM
Barrington Research Downgrades SurModics (SRDX) to Underperform Nov 14, 2025 07:39AM
Court denies injunction blocking Surmodics acquisition by GTCR Nov 11, 2025 03:35AM
SurModics (SRDX) Halted, News Pending Nov 10, 2025 02:45PM
Surmodics reports 91.7% success rate for Pounce thrombectomy device Nov 4, 2025 06:16AM


Nov 3, 2025 07:50AM Surmodics presents data on thrombectomy device at VIVA conference
Oct 29, 2025 04:21PM Surmodics reports sex-specific results from Pounce thrombectomy study
Apr 30, 2025 07:12AM SurModics (SRDX) Misses Q2 EPS by 4c, provides guidance
Apr 22, 2025 07:07AM SurModics (SRDX) Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon
Apr 3, 2025 07:02AM SurModics (SRDX) Announces Commercial Release of Pounce XL Thrombectomy System
Mar 6, 2025 09:01PM SurModics (SRDX) issues Statement on FTC Challenge to Proposed Acquisition by Funds Affiliated with GTCR
Jan 30, 2025 07:03AM SurModics (SRDX) Tops Q1 EPS by 8c
Nov 6, 2024 07:22AM SurModics (SRDX) Tops Q4 EPS by 7c
Oct 30, 2024 02:31PM SurModics (SRDX) Announces Early Results from PROWL Registry Study of Real-World Limb Ischemia Patients Treated with Pounce Thrombectomy System
Oct 1, 2024 07:00AM SurModics (SRDX) Receives FDA 510(k) Clearance for Pounce XL Thrombectomy System
Aug 13, 2024 07:41AM SurModics (SRDX) receives request for additional information from FTC on merger
Jul 31, 2024 07:05AM SurModics (SRDX) Tops Q3 EPS by 7c, suspends previous guidance